Exactech/Genzyme Biosurgery
This article was originally published in The Gray Sheet
Executive Summary
Exclusive worldwide license is granted to Exactech for the use of Genzyme's Focal synthetic bioabsorbable polymer technologies in developing new bone restoration products, the firms announce April 2. In return, Exactech will be responsible for manufacturing and distributing products resulting from the collaboration and will make payments on future products to Genzyme...